MENU
ELVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Enliven Therapeutics (ELVN) Ownership - Who owns Enliven Therapeutics?
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more
Profile
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
46
Web
https://www.enliventherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
983.52M
P/E Ratio
N/A
Total Cash
313.44M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.40
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ELVN
Capitalization
984M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
313M
Total Cash/Share
6.40
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
310M
P/B Ratio
3.17
Cash Flow
N/A
Earnings
-1.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
49K
Current Ratio
19.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-104.24M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.79
Shares Held By Institutions
1.48B
Shares Outstanding - Current
49M
Total Liabilities
15.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-10.978
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
46
Web
https://www.enliventherapeutics.com